CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Telix Pharmaceuticals Limited Reports Qtrly Group Revenue Of $245 Million

By Reuters News

Oct 21 (Reuters) - Telix Pharmaceuticals Limited TLX.AX:

  • QTRLY GROUP REVENUE OF US$245 MILLION

  • REAFFIRMED THAT FY 2026 REVENUE AND OTHER INCOME IS EXPECTED TO BE IN EXCESS OF US$1 BILLION

  • REVENUE TRACKING IN LINE WITH UPPER END OF FY 2026 GUIDANCE OF US$950 MILLION TO US$970 MILLION PLUS US$40 MILLION OF OTHER INCOME

  • REVISES FY 2026 RESEARCH AND DEVELOPMENT EXPENDITURE GUIDANCE RANGE TO US$240 MILLION TO US$260 MILLION


Further company coverage: TLX.AX

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk